Stock listing
Medigen Vaccine Biologics Corp.
Selected listing: 6547 · TPEX · TWD · TW
Medigen Vaccine Biologics Corp. (TPEx:6547), Health Technology. Latest release Mar 18, 2026: MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine…
- Ticker
- TPEx:6547
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TPEx
- Currency
- TWD
About Medigen Vaccine Biologics Corp.
Medigen Vaccine Biologics Corp. is a publicly traded company on the Taiwan stock market under the ticker 6547. Medigen focuses on the development and production of vaccines, contributing to public health initiatives.
Latest news from Medigen Vaccine Biologics Corp.
MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization in Vietnam; Joins Forces with Substipharm Biologics to Expand Southeast Asian Market
March 17, 2026
Medigen Vaccine Biologics : Announcement of the company's resolutions on the stock dividend ex-rights base date
July 14, 2022
Medigen Vaccine Biologics : Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase
July 1, 2022
Medigen Vaccine Biologics : Subscription rights to the cash issue forfeited by directors of the Company reaching 50% and subscription being made available to specific persons
June 10, 2022
Medigen Vaccine Biologics : Additional update on clinical development on MVC COVID-19 vaccine in the WHO COVID-19 Solidarity Trial Vaccines (Supplementary Announcement)
June 8, 2022
Research Medigen Vaccine Biologics Corp.
Medigen Vaccine Biologics Corp. company profile
View the public company page for Medigen Vaccine Biologics Corp. on 6ix.
Medigen Vaccine Biologics Corp. news
Read company news and market updates connected to Medigen Vaccine Biologics Corp..
Medigen Vaccine Biologics Corp. investor events
Find investor webinars, events, and replay context for Medigen Vaccine Biologics Corp..